C&CAUSES & WHAT WE KNOW
Causes & What We Know/November 21, 2026/3 min read

New Blood Test May Help Spot Kidney Damage Early in Children with Severe Diabetes Episodes

Researchers found that a nutritional marker measured at hospital admission could help doctors identify which children with diabetic ketoacidosis are at risk for acute kidney injury—potentially allowing for faster treatment.

Research summaryPubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

  • About 3 in 10 children hospitalized with diabetic ketoacidosis (DKA) develop acute kidney injury (AKI), a serious complication that can be hard to detect early
  • A blood test called the Prognostic Nutritional Index (PNI), measured when a child arrives at the hospital, was independently linked to AKI risk in this study
  • This finding suggests PNI might help doctors identify high-risk patients sooner, before traditional kidney markers show damage
  • The research is exploratory and was conducted in one hospital setting; more studies are needed to confirm whether PNI testing would improve patient care in practice

What This Study Examined

Diabetic ketoacidosis (DKA) is a serious medical emergency that occurs when blood sugar becomes dangerously high and the body produces too many acids. In this condition, some children develop acute kidney injury (AKI)—damage that temporarily reduces how well the kidneys filter waste and fluid.

Doctors typically rely on a blood marker called serum creatinine to detect kidney damage, but this test may take time to show changes after injury begins. Researchers wanted to know whether two other blood measurements—the Systemic Inflammatory Response Index (SIRI) and the Prognostic Nutritional Index (PNI)—might spot AKI risk earlier.

What Researchers Found

The study included 122 children with Type 1 diabetes who were hospitalized with DKA. Blood samples taken at admission were used to calculate SIRI and PNI scores. About 30% of the children (36 out of 122) developed acute kidney injury.

When researchers analyzed the data, they found that PNI remained associated with AKI risk even after accounting for other factors like hydration status and kidney function markers. Each increase in PNI was linked to higher odds of developing kidney damage. SIRI, by contrast, did not show a significant independent link to AKI in the adjusted analysis.

The researchers created a prediction model using PNI and other clinical variables, then tested how well it could identify which children would develop AKI. This kind of tool could eventually help doctors prioritize monitoring and care.

What This Means and What Remains Unknown

If confirmed in larger studies, a simple blood test measuring PNI at hospital arrival could help doctors flag children at higher risk for kidney damage during DKA. Early identification might allow for closer monitoring and faster intervention.

However, this was a single-center retrospective study—meaning researchers looked back at medical records rather than following patients forward in time. The findings need to be tested in other hospitals and patient populations before PNI screening becomes standard practice. It is also unclear whether using PNI to identify high-risk children would actually change treatment decisions or improve outcomes.

What Questions Remain

Future research should test whether PNI performs as well in other hospitals and regions. Studies are also needed to determine whether PNI-based risk flagging leads to real improvements in patient care and kidney outcomes. Additionally, researchers should explore why PNI appears linked to AKI in DKA, and whether the relationship reflects hemoconcentration (thickened blood from dehydration) or other mechanisms.

Evidence label

Source: European journal of pediatrics. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

From Type1Cure

Read more of our own writing in Stories

More evidence-labeled coverage across the Type1Cure library.